CAR T-cell Therapy Market Could Logs Over Plump Growth with a CAGR of 32.5 % Over the Forecast Period 2021 – 2028

CAR T-cell Therapy Market – Overview

There are two types of CAR T-cell therapy, intravenous and oral. Intravenous therapy uses the medicine to administer the cells directly into the bloodstream. Oral therapy is a process that is used during the clinical trials of various types of cancers. This oral therapy is supposed to help boost the immune system of the patient so that the body is better able to fight off the tumors once they begin. Both of these therapies have shown very good results in different clinical trials with various types of malignancies. The global CAR T-cell therapy market focuses on six regions namely North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The global CAR T-cell therapy market is expected to witness significant growth during the forecast period, owing to ongoing R&D activities in the field of oncology.

The global CAR-T Cell therapy market is estimated to be valued at US$ 295.1 million in 2018 and is expected to witness a CAGR of 32.5 % over the forecast period (2021 – 2028).

Request for Sample Copy of Report with Analysis of COVID-19 Impact on CAR T-cell Therapy Market – https://www.stratagemmarketinsights.com/sample/13213

CAR T-cell Therapy Market – Drivers

Rising prevalence of cancers is expected to drive growth in the global CAR T-cell therapy market during the forecast period. According to the World Health Organization (WHO), in 2018, around 9.6 million died due to cancer with over 300,000 new cases of cancer being diagnosed each year among children aged 0-19 years across the globe. CAR T-Cell Therapy is witnessing higher adoption in cancer treatment as it does not require aggressive chemotherapy. Hence, such factors are expected to drive the growth of the global CAR T-cell therapy market during the forecast period. Furthermore, ongoing R&D activities in the field of oncology are expected to propel the global CAR T-cell therapy market growth over the forecast period.

CAR T-cell Therapy Market – Restraint

Side-effects associated with CAR T-cell therapy, which could lead to cytokine release syndrome are expected to hinder the global CAR T-cell therapy market growth over the forecast period.

CAR T-cell Therapy Market – Regional Insights

Among regions, North America is expected to witness significant growth in the global CAR T-cell therapy market during the forecast period. This is owing to the presence of strong research and rising clinical trials associated with T-cell therapies in the U.S. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to rising government investment in T-cell therapy R&D.

Key Regions:

North America (the United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of the Middle East & Africa)

CAR T-cell Therapy Market – Competitive Section

Major companies involved in the global CAR T-cell therapy market are Pfizer, Novartis, Kite Pharma, Cellectis, and Juno Therapeutics.

For instance, in April 2021, Bristol Myers Squibb received the U.S. Food and Drug Administration (FDA) approval for idecabtagene vicleucel (Abecma) indicated for multiple myeloma.

Inquire To Know More About CAR T-cell Therapy Market Report @ https://www.stratagemmarketinsights.com/quiry/13213

Market Taxonomy

This report segments the CAR T-cell therapy market on the basis of antigen type, and therapeutic applications. On the basis of antigen, CAR T-cell therapy market is segmented as CD 19, CD 20, GD2, CD22, CD30, CD33, HER1, HER2, Meso, EGFRvlll, and others.

On the basis of therapeutic applications, the CAR T-cell therapy market is segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, non-hodgkin leukemia, multiple myeloma, pancreatic cancer, neuroblasta, breast cancer, acute myeloid leukemia, hepatocellular carcinoma, colorectal cancer, and other therapeutic applications.

The main questions of this study:

• CAR T-cell Therapy Why is the market suitable for long-term investment?
• Do you know the areas of the value chain where players can create value?
• In which regions can CAGR and Y-O-Y growth sharply increase?
• Which geographic regions have better demand for your products/services?
• What opportunities will emerge regions CAR T-cell Therapy present to existing and new entrants in the market?
• Analysis of risk aspects associated with service providers?
• What are the factors driving the demand for CAR T-cell Therapy in the next few years?
• What is the impact analysis of the various factors of the global CAR T-cell Therapy market growth?
• What strategies do large companies have to help them gain share in mature markets?
• How is the technology and customer-centric innovation of CAR T-cell Therapy making a big difference in the marketplace?

Most Frequently Questions Asked to Us:

• What is the current market size and compound annual growth rate (CAGR) of the market during the forecast period (2021-2028)?
• What are the major factors driving the market growth?
• What are the key factors hampering the growth of the market?
• Which are the major players operating in the market?

“Limited Period Offer”

Buy This Complete Business Report @ https://www.stratagemmarketinsights.com/cart/13213

About Us:

Stratagem Market Insights is a management consulting organization providing market intelligence and consulting services worldwide. We bring the expertise of consultants with a cumulative industry experience of more than 70 years. The firm has been providing quantified B2B research and currently offers services to over 350+ customers worldwide. We strive to offer sapient solutions, expert consultations, and tailored/customized solutions. Our team includes analysts that leverage their years of experience and expertise to create accurate and error-free reports. The domain-specific teams are constantly focused on tracking markets, aiding our clients to gain a competitive edge through high-quality market intelligence. We offer an array of services including, syndicated research, advisory and consulting research process outsourcing, and content management.

Contact Us:

Mr. Shah
Stratagem Market Insights
1001 4th Ave, #3200 Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027 / JAPAN +815055391737
Email: sales@stratagemmarketinsights.com